Design of Potent IGF1-R Inhibitors Related to Bis-azaindoles
Nemecek, C., Metz, W.A., Wentzler, S., Ding, F.X., Venot, C., Souaille, C., Dagallier, A., Maignan, S., Guilloteau, J.P., Bernard, F., Henry, A., Grapinet, S., Lesuisse, D.(2010) Chem Biol Drug Des 76: 100-106
- PubMed: 20545947 
- DOI: https://doi.org/10.1111/j.1747-0285.2010.00991.x
- Primary Citation of Related Structures:  
3LVP - PubMed Abstract: 
From an azaindole lead, identified in high throughput screen, a series of potent bis-azaindole inhibitors of IGF1-R have been synthesized using rational drug design and SAR based on a in silico binding mode hypothesis. Although the resulting compounds produced the expected improved potency, the model was not validated by the co-crystallization experiments with IGF1-R.
Organizational Affiliation: 
Medicinal Chemistry, Sanofi-Aventis, 13 Quai Jules Guesde, 94300 Vitry-sur-Seine, France.